Comparisons of false negative rates from a trend test alone and from a trend test jointly with a control-high groups pairwise test in the determination of the carcinogenicity of new drugs

References

• Dinse, G. E. (1985). Testing for a trend in tumor prevalence rates: I. nonlethal tumors. Biometrics 41:751–770.
   PubMed Web of Science ®Google Scholar
• Haseman, J. K. (1983). A reexamination of false-positive rates for carcinogenesis studies. Fundamental and Applied Toxicology 3:334–339.
   PubMedGoogle Scholar
• Haseman, J. K. (1984). Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies. Environmental Health Perspective 58:385–392.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH) (1988), Guideline S1B, Testing for Carcinogenicity of Pharmaceuticals.
   Google Scholar
• Lin, K. K. (1988). Peto prevalence method versus regression methods in analyzing incidental tumor data from animal carcinogenicity experiments: an empirical study. 1988 American Statistical Association Annual Meeting Proceedings (Biopharmaceutical Section). New Orleans, Louisiana.
   Google Scholar
• Lin, K. K. (1995). A regulatory perspective on statistical methods for analyzing new drug carcinogenicity study data. Bio/Pharam Quarterly 1(2):18–20.
   Google Scholar
• Lin, K. K. (1997). Control of overall false positive rates in animal carcinogenicity studies of pharmaceuticals. Presented at 1997 FDA Forum on Regulatory Sciences, December 8-9, 1997, Bethesda, Maryland.
   Google Scholar
• Lin, K. K. (2000a). Carcinogenicity studies of pharmaceuticals. In S. C. Chow, (edited by.), Encyclopedia of Biopharmaceutical Statistics. New York: Marcel Dekker. pp. 88–103.
   Google Scholar
• Lin, K. K. (2000b). A progress report on the guidance for industry for statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals. Journal of Biopharmaceutical Statistics 10:481–501.
   PubMedGoogle Scholar
• Lin, K. K., Ali, M. W. (2006). Statistical review and evaluation of animal carcinogenicity studies of pharmaceuticals. In C. R. Buncher, J. Y. Tsay, (Eds.), Statistics in the Pharmaceutical Industry, Third. New York: Chapman & Hall/CRC.
   Google Scholar
• Lin, K. K., Rahman, M. A. (1998). Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs. Journal of Pharmaceutical Statistics with discussions 8(1):1–22.
   Google Scholar
• Lin, K. K., Thomson, S. F., Rahman, M. A. (2010). The design and statistical analysis of toxicology studies. In G. Jagadeesh, S. Murthy, Y. Gupta, A. Prakash, (Eds.), Biomedical Research: From Ideation to Publications, 1st ed. India: Wolters Kluwer.
   Google Scholar
• Lin, K. K., Jackson, M. T., Min, M., Rahman, M. A., Thomson, S. F. (2016). Recent research projects by the FDA’s Pharmacology and Toxicology Statistics Team. In L. Zhang, (Eds.), Nonclinical Biostatistics for Pharmaceutical and Biotechnology Industries. New York: Springer.
   Google Scholar
• Peto, R., Pike, M. C., Day, N. E., Gray, R. G., Lee, P. N., Parish, S., Peto, J., Richards, S., Wahrendorf, J. (1980). Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In Long-Term and Short-Term Screening Assays for Carcinogens: A Critical Appraisal, 2 Suppl., 311-426, Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Rahman, A. M., Lin, K. K. (2008). A comparison of false positive rates of Peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and Rahman. Journal of Biopharmaceutical Statistics 18(5):849–858.
   Web of Science ®Google Scholar
• Rahman, A. M., Lin, K. K. (2009). Design and analysis of chronic carcinogenicity studies of pharmaceuticals in rodents. In K. E. Peace, (Eds.), Design and Analysis of Clinical Trials with Time-to-Event Endpoints. Boca Raton, FL: Chapman & Hall/CRC, Taylor & Francis Group, LLC.
   Google Scholar
• Rahman, M. A., Lin, K. K. (2010). Statistics in pharmacology. In G. Jagadeesh, S. Murthy, Y. Gupta, A. Prakash, (Eds.), Biomedical Research: From Ideation to Publications, 1st ed. India: Wolters Kluwer (India).
   Google Scholar
• U.S. Department of Health and Human Services. (2001). Guidance for Industry, Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals. Maryland, US: Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services.
   Google Scholar